OPKO Health Inc. (OPK) News
Filter OPK News Items
OPK News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OPK News Highlights
- For OPK, its 30 day story count is now at 3.
- Over the past 28 days, the trend for OPK's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about OPK are AMP, LI and SAVE.
Latest OPK News From Around the Web
Below are the latest news stories about OPKO HEALTH INC that investors may wish to consider to help them evaluate OPK as an investment opportunity.
OPKO Health commences private offering of convertible senior notesMore on OPKO Health... |
Here's Why You Should Retain OPKO Health (OPK) Stock for NowOPKO Health's (OPK) potential in Rayaldee raises optimism about the stock. |
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and TestingBioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data ("RWD") for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions to inform clinical studies and improve patient outcomes. Combining genetic data and critical biomarkers, means targeted precision therapies ba |
Phillip Frost Spends US$1.3m On OPKO Health StockThose following along with OPKO Health, Inc. ( NASDAQ:OPK ) will no doubt be intrigued by the recent purchase of shares... |
Q3 2023 OPKO Health Inc Earnings CallQ3 2023 OPKO Health Inc Earnings Call |
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues TopDespite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances. |
OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call TranscriptOPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript November 6, 2023 OPKO Health, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.09. Operator: Hello and welcome to the OPKO Health Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there […] |
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, will implement SOPHiA GENETICS' technology and add MSK-ACCESS® liquid biopsy to its test suite. With the implementation of SOPHiA GENETICS, BioReference will be the first laboratory globally to adopt MSK-ACCESS® powered with SOPHiA DDM™. The |
Opko Health (OPK) Q3 2023 Earnings Call TranscriptImage source: The Motley Fool. Opko Health (NASDAQ: OPK)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorHello, and welcome to the OPKO Health third quarter 2023 financial results conference call. |